Page URL:

First patient receives stem cell transplant in Parkinson's trial

12 November 2018
Appeared in BioNews 975

A male patient in his fifties has received a stem cell transplant into the brain in an early phase clinical trial for Parkinson's disease. 

The patient will be monitored for two years and given immune suppressing drugs to minimise the risk of rejection. The cells were dopamine-producing neurons made from induced pluripotent stem (iPS) cells from a donor. 

'We made a hole in the frontal part of the head's left side and transplanted some 2.4 million cells,' Dr Takayuki Kikuchi, a surgeon at Kyoto University Hospital in Japan who performed the three-hour operation, said at a press conference.

The first transplant is intended to ensure that the procedure is safe and to monitor for complications. The researchers report that so far, the patient has had no adverse reactions to the cells. If the patient continues to tolerate the treatment, six more Parkinson's patients will be enrolled in the trial. 

The iPS cells were injected into the left side of the patient's brain with a view to repeating the procedure on the right side in six months' time, reports Japan's national broadcaster NHK. The treatment aims to replenish the brain cells that produce dopamine, which are lost in Parkinson's disease, leading to debilitating symptoms of tremors and movement difficulties. 

'The best scenario is to see patients improve to the extent they do not have to take any medicine,' Professor Jun Takahashi of the university's Centre for iPS Cell Research and Application who led the research team, said at the press conference. Professor Takahashi added that the aim was to mass-produce viable nerve cells from iPS cells to produce a treatment that could be scaled up commercially. 

'Cell therapy offers the possibility of replacing neurons that are lost in neurodegenerative diseases, such as Parkinson's and Alzheimer's,' said Dr Todd Sherer, chief executive of the Parkinson's charity the Michael J. Fox Foundation, said when the trial was announced earlier this year (see BioNews 961). 

'The goal of these therapies is to restore function to people affected by this disease, essentially reversing disease course.'

Japan team transplants stem cells into brain to treat Parkinson's
Channel News Asia |  9 November 2018
Kyoto University performs world’s first iPS cell transplant for Parkinson’s
Japan Times |  9 November 2018
Kyoto Univ. performs world's 1st iPS cell transplant for Parkinson's
Nikkei Asian Review |  9 November 2018
20 January 2020 - by Emma Laycock 
A new study suggests that rare harmful mutations in young healthy donors' stems cells can be passed on to recipients of stem cell transplants, potentially leading to health problems...
27 August 2019 - by Jen Willows 
A new study has shown why stem cell transplants, even derived from the patient's own cells can be rejected...
3 December 2018 - by Caroline Casey 
A gene therapy relieves Parkinson's disease symptoms by rewiring the brain circuits involved in movement...
8 October 2018 - by Antony Starza-Allen 
Japan has introduced draft guidelines on genome editing that would permit the use of the approach, including CRISPR/Cas9, in human embryos for research purposes...
1 October 2018 - by Dr Helen Robertson 
A shortage of sperm donors has forced a Japanese hospital to stop offering couples a certain type of fertility treatment...
6 August 2018 - by Caroline Casey 
A first-of-its-kind clinical trial has been announced, which will use induced pluripotent stem cells to treat Parkinson's disease patients...
4 September 2017 - by Caroline Casey 
Neurons derived from human stem cells have successfully been used to treat and relieve symptoms of Parkinson's disease in a primate animal model...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.